Lisa Bodei

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 17 papers. Top paper: “Radiotheranostics in oncology: current challenges and emerging opportunities”.

Radiotheranostics in oncology: current challenges and emerging opportunities

Nature Reviews Clinical Oncology(2022)10.1038/s41571-022-00652-y

N/A

8.6DataRank · unranked

389 citations

Ken Herrmann, Heiko Schöder, Andrew M. Scott, Jason S. Lewis, Lisa Bodei

Imaging with [89Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumours of the lung and prostate: a phase 1/2, first-in-human trial

The Lancet Oncology(2024)10.1016/s1470-2045(24)00249-3

N/A

1.4DataRank · unranked

50 citations

Mark Dunphy, Matthew Agee, Joseph O'Donoghue, Rania G. Aly, Noura J. Choudhury +14 more

The Quest for an Accurate Functional Tumor Volume with 68Ga-DOTATATE PET/CT

Journal of Nuclear Medicine(2021)10.2967/jnumed.121.262782

N/A

1.1DataRank · unranked

19 citations

C. Ross Schmidtlein, Romina Grazia Giancipoli, Audrey Mauguen, Daniel Lafontaine, Heiko Schöder +2 more

Radiopharmaceutical therapy in cancer: clinical advances and challenges

Nature Reviews Drug Discovery(2020)10.1038/s41573-020-0073-9

N/A

1.0DataRank · unranked

875 citations

Lisa Bodei, Michael R. McDevitt, Jessie R. Nedrow, George Sgouros

Molecular profiling of neuroendocrine tumours to predict response and toxicity to peptide receptor radionuclide therapy

The Lancet Oncology(2020)10.1016/s1470-2045(20)30323-5

N/A

0.652DataRank · unranked

76 citations

Heiko Schöder, Richard P. Baum, Ken Herrmann, Jonathan Strosberg, Martyn Caplin +3 more

A simple strategy to reduce the salivary gland and kidney uptake of PSMA-targeting small molecule radiopharmaceuticals

European Journal of Nuclear Medicine and Molecular Imaging(2021)10.1007/s00259-020-05150-w

N/A

0.584DataRank · unranked

48 citations

Sang Gyu Lee, Katerina Jou, Goutam Chakraborty, Myrto Skafida, Scott T. Tagawa +9 more

Approach to the Treatment of a Patient with an Aggressive Pituitary Tumor

The Journal of Clinical Endocrinology & Metabolism(2020)10.1210/clinem/dgaa649

N/A

0.500DataRank · unranked

27 citations

Mark T.A. Donoghue, Sharon L. Wardlaw, Jonathan T. Yang, Lisa Bodei, Viviane Tabar +2 more

First-in-human imaging with [ 89 Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumors of the lung and prostate

medRxiv(2024)10.1101/2024.01.10.24301109

N/A

0.297DataRank · unranked

5 citations

Mark Dunphy, Matthew Agee, Joseph A. O’Donoghue, Rania G. Aly, Noura J. Choudhury +14 more

Delta-like ligand 3 expression and functional imaging in gastroenteropancreatic neuroendocrine neoplasms

medRxiv(2025)10.1101/2025.06.24.25330227

N/A

0.165DataRank · unranked

2 citations

Salomon Tendler, Joanne F. Chou, Zeynep Tarcan, Courtney Porfido, Jonathan Willner +20 more

Symptomatic Prostate-Specific Membrane Antigen PET–Positive Radionecrosis After Multimodality Brain Metastasis–Directed Treatment Including [177Lu]Lu-PSMA-617

Journal of Nuclear Medicine(2025)10.2967/jnumed.124.269175

N/A

0.104DataRank · unranked

1 citations

Kenny Yu, Wassim Abida, Luke Pike, Milan Grkovski, Thomas Kaley +10 more

A simple strategy to reduce the salivary gland and kidney uptake of PSMA targeting small molecule radiopharmaceuticals

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.07.24.220277

N/A

0DataRank · unranked

13 citations

Sang Gyu Lee, Katerina Jou, Goutam Chakraborty, Myrto Skafida, Scott T. Tagawa +9 more

Differential Clearance of [ 177 Lu]Lu-PSMA-617 from Metastatic Prostate Cancer Lesions and Normal Tissues creates a Window for Safe Application of DNA Repair Inhibitors

medRxiv(2025)10.1101/2025.10.08.25337591

N/A

0DataRank · unranked

0 citations

Milan Grkovski, Joseph A. O’Donoghue, Alexandre França Velo, Simone Krebs, Lisa Bodei +3 more

Synergism of Checkpoint Inhibitors and Peptide Receptor Radionuclide Therapy in the Treatment of Pituitary Carcinoma

Journal of the Endocrine Society(2021)10.1210/jendso/bvab133

N/A

0DataRank · unranked

41 citations

Viviane Tabar, Robert J. Young, Marc A. Cohen, John Cuaron, Jonathan T. Yang +5 more

Molecular identification of bronchopulmonary neuroendocrine tumours and neuroendocrine genotype in lung neoplasia using the NETest liquid biopsy

European Journal of Cardio-Thoracic Surgery(2020)10.1093/ejcts/ezaa018

N/A

0DataRank · unranked

12 citations

Kjell Öberg, Anna Malczewska, Anna Lewczuk, Matteo Roffinella, Harry R. Aslanian +2 more

The Future of Targeted α-Therapy Is Bright, but Rigorous Studies Are Necessary to Advance the Field

Journal of Nuclear Medicine(2022)10.2967/jnumed.122.264805

N/A

0DataRank · unranked

10 citations

Ken Herrmann, Lisa Bodei, Jonathan Strosberg

Consensus report of the 2021 National Cancer Institute neuroendocrine tumor clinical trials planning meeting

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad096

N/A

0DataRank · unranked

9 citations

Thomas A. Hope, Emily B Bergsland, Lisa Bodei, David Bushnell, Jennifer A. Chan +63 more

Neuroendocrine Tumor Therapy Response Assessment

PET Clinics(2023)10.1016/j.cpet.2022.11.009

N/A

0DataRank · unranked

5 citations

Lisa Bodei, Vetri Sudar Jayaprakasam